Soleno Therapeutics’ $120 Million Common Stock Offering and Private Placement

Wilson Sonsini Goodrich & Rosati and Cooley advised Soleno Therapeutics on the deal.Soleno Therapeutics, Inc. (Nasdaq:SLNO), (“Soleno”) announced the pricing of the underwritten public offering of 3,000,000…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now